VeinViewer has undergone ten stringent peer reviews since 2006.
Third-party medical peer reviews demonstrate the statistically
significant clinical effectiveness of VeinViewer, and often evaluate
potential savings to the bottom line.
VeinViewer technology was developed with the aid of the engineering
capabilities and resources of parent company Christie Digital Systems, a
leading global visual technology firm with more than 80 years of
experience in the projection systems industry. VeinViewer is the first
and only device on the market to use: harmless near-infrared light, DLP®
technologies, exclusive technology such as Active Vascular Imaging
Navigation (AVIN™) providing the demanded Pre, During and Post-access
(PDP) benefits, TrueView imaging accuracy in projected vein-widths which
is three to ten times more accurate than competition, and technologies
such as Df2 (Digital full field) to illuminate the
only real-time HD digital image of subcutaneous vasculature and blood
patterns directly onto the skin surface. Although designed for
assistance in IV starts and blood draws, VeinViewer has proven
beneficial in spider and varicose vein treatment.
To learn more about Christieproduct offerings please visit www.veinviewer.com.
About Christie Medical Holdings, Inc.
Christie Medical Holdings Inc. is a global company based in Memphis,
Tenn., that discovers, develops and commercializes medical technologies.
The company’s market-leading product, VeinViewer®, is a mobile vascular
imaging system that allows health care providers to clearly see
accessible vasculature as a real time HD image, directly on the surface
of the skin. Christie Medical Holdings Inc. is owned by Christie Digital
Systems Inc., a global visual technologies company and a subsidiary of
Ushio Inc., Japan (JP:6925). For more information on Christie Digital
Systems or Christie Medical Holdings, visit www.christiedigital.com.
Follow us on Twitter @veinviewer
DLP® is a registered trademark of Texas Instruments.
Christie Medical Holdings, Inc.
Carmen Robert, 519-572-5824
Source: Christie Medical Holdings, Inc.